Melville Tahlia, Vardy Katie, Milliner Lucy, Angus Rebecca
Nutrition and Food Services, Gold Coast Hospital and Health Service, Southport, Queensland, Australia
Nutrition and Food Services, Gold Coast Hospital and Health Service, Southport, Queensland, Australia.
BMJ Case Rep. 2020 Mar 19;13(3):e233346. doi: 10.1136/bcr-2019-233346.
This case study reports on the use of intradialytic parenteral nutrition (IDPN) to address severe malnutrition in a 38-year-old woman, redo double lung transplant recipient with a complex medical history including cystic fibrosis and end-stage renal disease (ESRD) on haemodialysis. Gastroparesis and severe postprandial abdominal pain limited oral/enteral nutrition input. The addition of IDPN resulted in a dry weight increase of 13.6% over a 12-month period and an improvement in the patient's malnutrition status from severe (Patient-Generated Subjective Global Assessment (PG SGA) C24) to moderate (PG SGA B7). The patient stated she would recommend IDPN to others in a similar situation. Management of patients with coexisting cystic fibrosis and ESRD with or without haemodialysis requires patient engagement in treatment planning and a multidisciplinary team approach for clinical judgement in the absence of guidelines. As advances in medical care see more patients with these coexisting conditions, IDPN may provide an increasingly useful adjunct therapy.
本病例研究报告了一位38岁女性再次进行双肺移植受者使用透析期间胃肠外营养(IDPN)治疗严重营养不良的情况。该患者有复杂的病史,包括囊性纤维化和终末期肾病(ESRD),正在接受血液透析。胃轻瘫和严重的餐后腹痛限制了口服/肠内营养的摄入。在12个月的时间里,添加IDPN使患者干重增加了13.6%,患者的营养不良状况从严重(患者主观整体评估(PG-SGA)C24)改善为中度(PG-SGA B7)。患者表示,她会向处于类似情况的其他人推荐IDPN。对于同时患有囊性纤维化和ESRD且接受或未接受血液透析的患者,在缺乏指南的情况下,治疗管理需要患者参与治疗计划,并采用多学科团队方法进行临床判断。随着医疗护理的进步,越来越多的患者患有这些并存疾病,IDPN可能会成为一种越来越有用的辅助治疗方法。